Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › florbetapir F 18

florbetapir F 18

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of florbetapir F 18

21 trials tracked of florbetapir F 18: 6 in phase 3 or 4 and 1 with published results. The most-cited published study has 53 citations.

21Trials tracked
6Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 5 Phase 2 6 Phase 1 6 Other / NA 3
  1. Phase 3 Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Completed · 53 cited
  2. Phase 4 Evaluation of Reader Training Processes Completed
  3. Phase 3 Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 Completed
  4. Phase 3 Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain Completed
  5. Phase 3 Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline Completed
  6. Phase 3 Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Completed
Show 15 more trials
  1. Phase 2 Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals Completed
  2. Phase 2 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy Completed
  3. Phase 2 A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) Completed
  4. Phase 2 Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Completed
  5. Phase 2 Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45) Completed
  6. Phase 2 Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients Completed
  7. Phase 1 A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease Completed
  8. Phase 1 Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects Completed
  9. Phase 1 A Preliminary Study of 18F-AV-45 in Alzheimer's Disease and Healthy Elderly Volunteers Completed
  10. Phase 1 A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers Completed
  11. Phase 1 A Study of 18F-AV-45 in Healthy Volunteers Completed
  12. Phase 1 A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers Completed
  13. N/A Evaluation of PET Scan Timing Relative to AV-45 Injection Time Completed
  14. N/A Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans Completed
  15. N/A Evaluation of Physician Training Methods to Read Florbetapir-PET Scans Completed

Showing the 21 most-cited and recently-updated of 21 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.